These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22491346)

  • 1. Why do phase III clinical trials in oncology fail so often?
    Amiri-Kordestani L; Fojo T
    J Natl Cancer Inst; 2012 Apr; 104(8):568-9. PubMed ID: 22491346
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier?
    Gyawali B; Addeo A
    Int J Cancer; 2018 Oct; 143(8):2079-2081. PubMed ID: 29744864
    [No Abstract]   [Full Text] [Related]  

  • 3. Examining heterogeneity in phase II trial designs may improve success in phase III.
    Tuma RS
    J Natl Cancer Inst; 2008 Feb; 100(3):164-6. PubMed ID: 18230788
    [No Abstract]   [Full Text] [Related]  

  • 4. Why did the study fail?
    Dellapasqua S; Castiglione-Gertsch M
    Eur J Cancer; 2005 Dec; 41(18):2784-6. PubMed ID: 16253501
    [No Abstract]   [Full Text] [Related]  

  • 5. [Randomizations!].
    Piedbois P; Buyse M
    Cancer Radiother; 1998 Dec; 2(6):663-4. PubMed ID: 9922769
    [No Abstract]   [Full Text] [Related]  

  • 6. Conservative local treatment versus mastectomy after induction chemotherapy in locally advanced breast cancer: a randomised phase III study (EORTC 10974/22002, LAMANOMA)--why did this study fail?
    Sinacki M; Jassem J; van Tienhoven G
    Eur J Cancer; 2005 Dec; 41(18):2787-8. PubMed ID: 16274985
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent reminders of why the gold standard for clinical research in oncology is the well-designed and conducted randomized phase III trial.
    Markman M
    Curr Oncol Rep; 2004 Nov; 6(6):421-2. PubMed ID: 15485610
    [No Abstract]   [Full Text] [Related]  

  • 8. Failures in Phase III: Causes and Consequences.
    Seruga B; Ocana A; Amir E; Tannock IF
    Clin Cancer Res; 2015 Oct; 21(20):4552-60. PubMed ID: 26473191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III clinical trials in oncology. 20-21 January 2003, London, UK.
    Buyse M
    IDrugs; 2003 Mar; 6(3):187-90. PubMed ID: 12838977
    [No Abstract]   [Full Text] [Related]  

  • 10. When are "positive" clinical trials in oncology truly positive?
    Ocana A; Tannock IF
    J Natl Cancer Inst; 2011 Jan; 103(1):16-20. PubMed ID: 21131576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response evaluation: beyond RECIST.
    Eisenhauer EA
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix29-32. PubMed ID: 17631592
    [No Abstract]   [Full Text] [Related]  

  • 12. [Status quo and problems in phase III trials: view of a trialist].
    Hamajima N
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):319-22. PubMed ID: 7880101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other paradigms: better treatments are identified by better trials: the value of randomized phase II studies.
    Sharma MR; Maitland ML; Ratain MJ
    Cancer J; 2009; 15(5):426-30. PubMed ID: 19826363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOP 09: Statistical design and analysis.
    Onkologie; 2003 Oct; 26 Suppl 6():43-7. PubMed ID: 23570186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
    Natale D; Orlando D
    Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
    [No Abstract]   [Full Text] [Related]  

  • 16. Multi-arm clinical trials of new agents: some design considerations.
    Freidlin B; Korn EL; Gray R; Martin A
    Clin Cancer Res; 2008 Jul; 14(14):4368-71. PubMed ID: 18628449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II trials: misleading and unreliable.
    Stewart DJ
    J Clin Oncol; 2010 Nov; 28(31):e649-50; author reply e651-3. PubMed ID: 20855829
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principle and practice of clinical phase III studies].
    Morant R
    Onkologie; 2008; 31 Suppl 2():53-7. PubMed ID: 18487870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial watch: pivotal oncology trials: outlook for Q2 2009.
    Nehring R
    Nat Rev Drug Discov; 2009 Apr; 8(4):266. PubMed ID: 19337264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.